Product news

Share this article:

The FDA has approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery. Evithrom is the first human thrombin approved since 1954 and is the only product currently licensed. It is derived from human plasma obtained from carefully screened and tested US donors and has undergone steps to further reduce the risk for transfusion-transmitted diseases. Evithrom is manufactured by Omrix Biopharmaceuticals of Ramat Gan, Israel, and will be distributed by Johnson & Johnson Wound Management, a division of Ethicon, in Somerville, NJ.

Ipsen has announced that the FDA has approved Somatuline Depot (lanreotide) Injection in 60, 90 and 120 mg. versions. Somatuline Depot is indicated for the long-term treatment of the hormonal disorder acromegaly in patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option. Somatuline Depot will be available in a pre-filled syringe eliminating any need for reconstitution and thus enabling freedom of easy administration to patients.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.